Key result
Absent cytokines yield non-cytotoxic neonatal CD8 T cells, increasing early-life MCMV lung disease risk.
Why the study?
Differential antiviral T cell immunity in early life impacts CMV clinical outcomes, but the underlying mechanisms are not well understood.
Does adoptive transfer of adult T cells or cytokine supplementation improve control of lung MCMV infection in neonatal mice?
Does adoptive transfer of adult T cells or cytokine supplementation improve control of lung MCMV infection in neonatal mice?
Defective CD8 T cell priming due to absent key cytokines in neonates explains the higher risk for MCMV lung disease in early life.
Answers are grounded in this paper and cite their sources.
Early-life T cell immunity may heighten infant CMV morbidity; leaves open age-adapted mechanistic therapies pending human validation.
Differential antiviral T cell immunity in early life impacts the clinical outcome of Cytomegalovirus (CMV) infection, but the underlying mechanisms are not well understood. T cells are known to be involved in protection from CMV disease. To further elucidate these mechanisms, we used a model of respiratory murine CMV (MCMV) infection and adoptive T cell transfers to characterize MCMV-specific T cell responses in early life. We analyzed the effector T cell differentiation using single-cell RNA sequencing and assessed the local pulmonary cytokine milieu. We found delayed enrichment of early-life murine MCMV-specific CD8 T cells due to a general deficiency of αβ T cells. Adoptive transfer of naïve adult T cells into neonates did not protect from lung MCMV infection due to generation of non-cytotoxic CD8 effector T cells. Furthermore, key cytokines required for effective CD8 T cell priming were absent in early life. Supplementation with these cytokines enhanced infection control by transferred adult T cells. The effector function of adult-primed T cells was not disrupted in neonates. Together, this study suggests defective CD8 T cell priming in neonates as a factor explaining the higher risk for MCMV lung disease in the early-life phase.
No takes yet. Share an insight, caveat, or question.
Brito et al. (2026) studied Murine cytomegalovirus (MCMV) infection. Adoptive T cell transfer and cytokine supplementation was evaluated on MCMV-specific T cell responses and infection control. Defective CD8 T cell priming in neonates, driven by absent key cytokines, leads to non-cytotoxic CD8 effector T cells and explains the higher risk for early-life MCMV lung disease.
Synapse has enriched 10 related papers. Consider them for comparative context: